Lori Handy, MD, provides guidance in these areas including presentation before rash onset, when patients should be considered for the inpatient setting, and what treatment looks like.
|Videos|December 15, 2017
Who Is in Charge of Infection Control Programs in Hospitals?
Author(s)Contagion® Editorial Staff
Michael Edmond, MD, MPH, MPA, explains who is in charge of leading infection control programs in hospitals.
Advertisement
Michael Edmond, MD, MPH, MPA, chief quality officer at the University of Iowa Hospitals & Clinics, explains who is in charge of leading infection control programs in hospitals.
Interview Transcript (modified slightly for readability):
“Particularly in larger hospitals, there’s an infection control program that is led by a health care epidemiologist; those are usually infectious disease physicians who often have additional training in public health, or specifically in health care epidemiology. They lead the program, and along with them, they work with infection preventionists, to implement the things that need to be done to make us ready for these pathogens that may come to bite us in the future.”
Advertisement
Related to this article
Jason Pogue, PharmD, BCPS, BCIDP, contextualizes preliminary data looking at this trial and other extended-spectrum beta-lactamase (ESBL) studies, which reopens the debate around carbapenem-sparing treatment options.
With a significant increase in rabies exposures this year, Rodney Rohde, PhD, talks about seeking medical attention after animal interactions as well as clinical treatment when people have been bit or scratched.
In the first episode of our new series looking at the food safety network, Lynette Johnston, PhD, offers insights into how the federal government surveillance infrastructure operates and how epidemiologists serve as food detectives in determining bacterial pathogens and potential foodborne outbreaks.
Food expert Lynette Johnston, PhD, provides some context around the ongoing outbreak, discusses prevention, and compares 2026 food recalls with previous years.
The Peggy Lillis Foundation will host its 17th Annual Changing the Odds Gala this month in New York City, and it will include a casino, fellowship amongst the C diff community, and an award ceremony honoring a physician-scientist, philanthropist, a researcher, and a patient advocate for their contributions to C difficile awareness, treatment, and prevention.
Resistance-guided testing targeting a single gene mutation could let clinicians safely reintroduce ciprofloxacin for the majority of gonorrhea cases still susceptible to it, sparing ceftriaxone as resistance climbs worldwide. Lao-Tzu Allan-Blitz, MD, MPH, offers insights into his work in this area.
Advertisement
Advertisement
Trending on Contagion Live
1
Clinical Considerations for Measles: Presentation, Treatment, and Hospitalization
2
FAQ: Rising Rabies Exposure Calls PEP Decisions Back in Focus
3
Measles Update: October 2, 2026
4
New IDSA/ESCMID S aureus Bacteremia Consensus Statements: a Risk Stratification Framework
5